JPH05993B2 - - Google Patents
Info
- Publication number
- JPH05993B2 JPH05993B2 JP9957884A JP9957884A JPH05993B2 JP H05993 B2 JPH05993 B2 JP H05993B2 JP 9957884 A JP9957884 A JP 9957884A JP 9957884 A JP9957884 A JP 9957884A JP H05993 B2 JPH05993 B2 JP H05993B2
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- carbamoyl
- buffer
- solution
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000006243 chemical reaction Methods 0.000 claims description 17
- 230000000694 effects Effects 0.000 claims description 17
- 102100036238 Dihydropyrimidinase Human genes 0.000 claims description 16
- 108091022884 dihydropyrimidinase Proteins 0.000 claims description 16
- 229940091173 hydantoin Drugs 0.000 claims description 15
- 150000001469 hydantoins Chemical class 0.000 claims description 15
- 150000008575 L-amino acids Chemical class 0.000 claims description 10
- 229910001429 cobalt ion Inorganic materials 0.000 claims description 8
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 claims description 8
- 239000000758 substrate Substances 0.000 claims description 5
- DQQLZADYSWBCOX-UHFFFAOYSA-N 2-(2,5-dioxoimidazolidin-4-yl)acetic acid Chemical compound OC(=O)CC1NC(=O)NC1=O DQQLZADYSWBCOX-UHFFFAOYSA-N 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- -1 N-carbamoyl-amino Chemical group 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 3
- 229910021645 metal ion Inorganic materials 0.000 claims description 3
- 239000010941 cobalt Substances 0.000 claims 1
- 229910017052 cobalt Inorganic materials 0.000 claims 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 description 39
- 102000004190 Enzymes Human genes 0.000 description 39
- 239000000243 solution Substances 0.000 description 23
- 239000000872 buffer Substances 0.000 description 19
- 238000004519 manufacturing process Methods 0.000 description 12
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 7
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 7
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 7
- 235000011130 ammonium sulphate Nutrition 0.000 description 7
- 239000007853 buffer solution Substances 0.000 description 7
- 235000002867 manganese chloride Nutrition 0.000 description 7
- 239000011565 manganese chloride Substances 0.000 description 7
- 229940099607 manganese chloride Drugs 0.000 description 7
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- IPWQOZCSQLTKOI-QMMMGPOBSA-N d-[(amino)carbonyl]phenylalanine Chemical compound NC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IPWQOZCSQLTKOI-QMMMGPOBSA-N 0.000 description 6
- DBOMTIHROGSFTI-UHFFFAOYSA-N 5-benzylimidazolidine-2,4-dione Chemical compound O=C1NC(=O)NC1CC1=CC=CC=C1 DBOMTIHROGSFTI-UHFFFAOYSA-N 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 238000002523 gelfiltration Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- NWLXJVDJMARXSP-JTQLQIEISA-N (2s)-2-(carbamoylamino)-3-(1h-indol-3-yl)propanoic acid Chemical compound C1=CC=C2C(C[C@H](NC(=O)N)C(O)=O)=CNC2=C1 NWLXJVDJMARXSP-JTQLQIEISA-N 0.000 description 4
- OIVLITBTBDPEFK-UHFFFAOYSA-N 5,6-dihydrouracil Chemical compound O=C1CCNC(=O)N1 OIVLITBTBDPEFK-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000003957 anion exchange resin Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- YFZOUMNUDGGHIW-UHFFFAOYSA-M p-chloromercuribenzoic acid Chemical compound OC(=O)C1=CC=C([Hg]Cl)C=C1 YFZOUMNUDGGHIW-UHFFFAOYSA-M 0.000 description 3
- 229960004799 tryptophan Drugs 0.000 description 3
- NBAKTGXDIBVZOO-UHFFFAOYSA-N 5,6-dihydrothymine Chemical compound CC1CNC(=O)NC1=O NBAKTGXDIBVZOO-UHFFFAOYSA-N 0.000 description 2
- KAVIACMZMOXBMP-UHFFFAOYSA-N 5-(indol-1-ylmethyl)imidazolidine-2,4-dione Chemical compound O=C1NC(=O)NC1CN1C2=CC=CC=C2C=C1 KAVIACMZMOXBMP-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108030006033 Carboxymethylhydantoinases Proteins 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- 102000007327 Protamines Human genes 0.000 description 2
- 108010007568 Protamines Proteins 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- ZRBROGSAUIUIJE-UHFFFAOYSA-N azanium;azane;chloride Chemical compound N.[NH4+].[Cl-] ZRBROGSAUIUIJE-UHFFFAOYSA-N 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 2
- 238000000326 densiometry Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229910001437 manganese ion Inorganic materials 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- 229950008679 protamine sulfate Drugs 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- VJUNTPRQTFDQMF-UHFFFAOYSA-N 1-benzylimidazolidine-2,4-dione Chemical compound O=C1NC(=O)CN1CC1=CC=CC=C1 VJUNTPRQTFDQMF-UHFFFAOYSA-N 0.000 description 1
- IPWQOZCSQLTKOI-UHFFFAOYSA-N 2-(carbamoylamino)-3-phenylpropanoic acid Chemical compound NC(=O)NC(C(O)=O)CC1=CC=CC=C1 IPWQOZCSQLTKOI-UHFFFAOYSA-N 0.000 description 1
- DGPBVJWCIDNDPN-UHFFFAOYSA-N 2-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=CC=C1C=O DGPBVJWCIDNDPN-UHFFFAOYSA-N 0.000 description 1
- PHENTZNALBMCQD-UHFFFAOYSA-N 3-ureidoisobutyric acid Chemical compound OC(=O)C(C)CNC(N)=O PHENTZNALBMCQD-UHFFFAOYSA-N 0.000 description 1
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
- 241000186073 Arthrobacter sp. Species 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N Aspartic acid Chemical compound OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010011945 N-carbamoyl-L-amino-acid hydrolase Proteins 0.000 description 1
- HLKXYZVTANABHZ-REOHCLBHSA-N N-carbamoyl-L-aspartic acid Chemical compound NC(=O)N[C@H](C(O)=O)CC(O)=O HLKXYZVTANABHZ-REOHCLBHSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- YVZLYNHKJASIHA-UHFFFAOYSA-L [Na+].[K+].OP(O)([O-])=O.OP(O)([O-])=O Chemical compound [Na+].[K+].OP(O)([O-])=O.OP(O)([O-])=O YVZLYNHKJASIHA-UHFFFAOYSA-L 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000011098 chromatofocusing Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000028564 filamentous growth Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- KMZJRCPGGAQHGC-UHFFFAOYSA-N trisodium boric acid borate Chemical compound [Na+].[Na+].[Na+].OB(O)O.[O-]B([O-])[O-] KMZJRCPGGAQHGC-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Description
ãç£æ¥äžã®å©çšåéã
æ¬çºæã¯ãæ°èŠãªããã³ãã€ããŒãŒã«é¢ããã
æŽã«è©³ããã¯ãïŒâ眮æããã³ãã€ã³ãéè£å æ°Ž
åè§£ããŠïŒ®âã«ã«ãã¢ã€ã«ââã¢ããé
žãçæ
ããæŽ»æ§ãæããæ°èŠããã³ãã€ããŒãŒã«é¢ã
ãã
ãåŸæ¥ã®æè¡ã
åŸæ¥ãïŒâ眮æããã³ãã€ã³ã«äœçšããããã³
ãã€ããŒãŒãšããŠã¯ãåçš®åç©ã®èèãè
èãè±
ç§æ€ç©ã埮çç©ã«ååšãããžããããŠã©ã·ã«ãŸã
ã¯ãžãããããã³ãéè£å æ°Žåè§£ããŠããããã
âã«ã«ãã¢ã€ã«âβâã¢ã©ãã³ãŸãã¯ïŒ®âã«ã«
ãã¢ã€ã«âβâã¢ããâã€ãœé
ªé
žã«å€æãããšãš
ãã«ãïŒâ眮æããã³ãã€ã³é¡ã«ãäœçšããç«äœ
ç¹ç°çã«éè£å æ°Žåè§£ããŠãå
åŠæŽ»æ§ïŒ®âã«ã«ã
ã¢ã€ã«ââã¢ããé
žé¡ã«å€æããäœçšããæã
ããžãããããªããžããŒãŒïŒEC3.5.2.2ïŒãç¥ã
ããŠããïŒç¹éæ53â136583ïŒã
äžæ¹ãïŒâ眮æããã³ãã€ã³ããâã«ã«ãã¢
ã€ã«ââã¢ããé
žãçæããé
µçŽ ãšããŠã¯ïŒ¬â
ïŒâã«ã«ããã·ã¡ãã«ããã³ãã€ã³ããâã«ã«
ãã¢ã€ã«ââã¢ã¹ãã©ã®ã³é
žãçæããã«ã«ã
ãã·ã¡ãã«ããã³ãã€ããŒãŒïŒEC3.5.2.4ïŒãç¥
ãããŠããïŒé
µçŽ ãã³ãããã¯æåæžåº1982幎çº
è¡ãp597ïŒã
ïŒâ眮æããã³ãã€ã³ããâã¢ããé
žãçæ
ãããæ¹æ³ãšããŠã¯ãç¹å
¬æ42â13850å·å
¬å ±ã«
ã¯å皮埮çç©ã®èäœåã¯å¹é€æ¶²ãç Žç æ¶²ãçšã
ãŠãâã¢ããé
žãçæãããæ¹æ³ãç¹å
¬æ45â
8633å·å
¬å ±ã«ã¯ïŒ¬âãªãžã³ã補é ããæ¹æ³ããã
ã«ç¹å
¬æ54â2274å·å
¬å ±åã³ç¹å
¬æ54â8749å·å
¬
å ±ã«ã¯ãã©ããã¯ããªã ã¢ããã²ãã¹ãäœçšãã
ãŠãïŒâ眮æããã³ãã€ã³ããâããšãã«ã¢ã©
ãã³åã³ïŒ¬âããªãããã¢ã³ã補é ããæ¹æ³ãé
瀺ãããŠãããæ¬çºæè
ãããïŒçœ®æããã³ãã€
ã³ã«ãã¢ãªã¹ããã¯ã¿ãŒå±DKâ200èæ ªãäœçš
ãããŠãâã¢ããé
žã補é ããæ¹æ³ããã§ã«æ
æ¡ããïŒç¹é¡æ59â70906å·æçŽ°æžïŒããããã®æ¹
æ³ã¯å»è¬ãååŠå·¥æ¥çšåæãé£åæ·»å ç©ãšããŠæ
çšãªïŒ¬âã¢ããé
žã®è£œé ã«æ¥µããŠæå¹ã§ãããå®
çšå¹æãæåŸ
ãããã
ãçºæã解決ããããšããåé¡ç¹ã
ããããªããããããã®ïŒ¬âã¢ããé
žã®è£œé æ³
ã«ãããŠãïŒâ眮æããã³ãã€ã³ãéè£å æ°Žåè§£
ããé
µçŽ ã«ã€ããŠã¯ãæããã«ãããŠããªããã
ã®ãããªé
µçŽ ãå
¥æã§ããã°æçšãªïŒ¬âã¢ããé
ž
ã®è£œé ãçµæžçã«è¡ãªããå·¥æ¥çå©çšäŸ¡å€ã¯å€§ã
ããããã§ãæ¬çºæè
ãã¯ãïŒâ眮æããã³ãã€
ã³ãããçžåœããâã¢ããé
žãçæããåå¿ã«
é¢äžãã埮çç©é
µçŽ ã«ã€ããŠç ç©¶ãè¡ãªã€ãçµ
æãã¢ãªã¹ããã¯ã¿ãŒå±ã®èæ ªããïŒâ眮æãã
ã³ãã€ã³ãéè£å æ°Žåè§£ããŠãâã«ã«ãã¢ã€ã«
ââã¢ããé
žã«å€æããé
µçŽ ãå¹çè¯ãå€éã«
çç£ããããšãèŠãåºããæ¬çºæã宿ããã«å°
ã€ãã
ãåé¡ç¹ã解決ããããã®ææ®µã
å³ã¡æ¬çºæã¯ãäžèšã®çååŠçæ§è³ªãæããäž
ã€ïŒâ眮æããã³ãã€ã³ãéè£å æ°Žåè§£ããŠïŒ®â
ã«ã«ãã¢ã€ã«ââã¢ããé
žãçæããæŽ»æ§ãæ
ããæ°èŠããã³ãã€ããŒãŒã§ããã
åºè³ªç¹ç°æ§ïŒïŒâã«ã«ããã·ã¡ãã«ããã³ãã€
ã³ã«äœçšããªãã
è³é©PHïŒïŒâ眮æããã³ãã€ã³ããã®å æ°Žåè§£
åå¿PH8.0ã9.0
âã«ã«ãã¢ã€ã«âã¢ããé
žããã®éåå¿
PH5.0ã7.0
å®å®PHç¯å²ïŒPH5.0ã10.0
äœçšé©æž©ã®ç¯å²ïŒ30ã40â
枩床å®å®æ§ã®ç¯å²ïŒ35âãŸã§ã¯å®å®
é»å®³å€ãéå±ã€ãªã³ã®åœ±é¿ïŒïœâã¯ããããŒã
ãŠãªãã³ãŸãšã€ãïŒPCMBïŒããšãã¬ã³ãž
ã¢ããããã©é
¢é
žã«ãã€ãŠé»å®³ããããã³
ãã«ãã€ãªã³ããã³ã¬ã³ã€ãªã³ãäºéã€ãª
ã³ã«ãã€ãп޻æ§ãä¿é²ããããã³ãã«ãã€
ãªã³ã¯ç±å®å®æ§ãåäžãããã
ä»¥äžæ¬çºæãããã«è©³çްã«èª¬æããã
å
ããæ¬é
µçŽ ã®çååŠçæ§è³ªã以äžã«èšèŒã
ãã
(1) äœçšåã³åºè³ªç¹ç°æ§
æ¬é
µçŽ ã¯ãïŒâ眮æããã³ãã€ã³ã®ïŒ¬äœåã³ïŒ€
äœã®éè£å æ°Žåè§£ãããããããçžåœããâã«
ã«ãã¢ã€ã«ââã¢ããé
žåã³ïŒ®âã«ã«ãã¢ã€ã«
ââã¢ããé
žã«å€æãããïŒâ眮æããã³ãã€
ã³ã®ãã¡ã眮æåºã«è³éŠç°ãæããïŒâãã³ãžã«
ããã³ãã€ã³ãïŒâã€ã³ããªã«ã¡ãã«ããã³ãã€
ã³çã«ãšãã«ããäœçšããã
ããããªãããïŒâã«ã«ããã·ã¡ãã«ããã³ã
ã€ã³ïŒDLâã¢ã¹ãã©ã®ã³é
žããã³ãã€ã³ïŒãDL
âã°ã«ã¿ãã³é
žããã³ãã€ã³åã³ããã³ãã€ã³ã«
ã¯äœçšããªããåŸã€ãŠãå
¬ç¥ã®ã«ã«ããã·ã¡ãã«
ããã³ãã€ããŒãŒãšã¯ç°ãªãæ°èŠã®ããã³ãã€ã
ãŒãŒã§ããã
ãŸããžããããŠã©ã·ã«ããžãããããã³ã«ã¯ã
ã»ãšãã©äœçšããããžãããããªããžããŒãŒãšã¯
ç°ãªãã
(2) è³é©PH è³é©PHã¯ç·©è¡æ¶²ãšããŠã¢ã³ã¢ãã¢ç·©
è¡æ¶²ïŒ0.05Mã¢ã³ã¢ãã¢æ°Žâå¡©åã¢ã³ã¢ããŠã
ç·©è¡æ¶²ãPH8.0ã10.0ïŒãçšããïŒâãã³ãžã«
ããã³ãã€ã³ãåºè³ªãšããæž©åºŠ35âã§30åéå
å¿ãããçæããâã«ã«ãã¢ã€ã«âDLâã
ãšãã«ã¢ã©ãã³ã枬å®ããå ŽåãPH8.0â9.0ã§
ããããŸãç·©è¡æ¶²ãšããŠãé
¢é
žç·©è¡æ¶²ïŒ0.05M
é
¢é
žâé
¢é
žãããªãŠã ç·©è¡æ¶²ãPH4.0â5.5ïŒãš
ãªã³é
žç·©è¡æ¶²ïŒ0.05Mãªã³é
žâã«ãªãŠã âãªã³
é
žäºãããªãŠã ç·©è¡æ¶²PH5.5ã8.0ïŒãçšãã
âã«ã«ãã¢ã€ã«ââããšãã«ã¢ã©ãã³åã¯ïŒ®
âã«ã«ãã¢ã€ã«ââããšãã«ã¢ã©ãã³ãåºè³ª
ãšããŠãïŒâãã³ãžã«ããã³ãã€ã³çæã枬å®
ããå Žåã®è³é©PH5.0ã7.0ã§ãããæ¬é
µçŽ ã¯ã
âã«ã«ãã¢ã€ã«ââã¢ããé
žåã³ïŒ®âã«ã«
ãã¢ã€ã«ââã¢ããé
žããïŒâ眮æããã³ã
ã€ã³ãçæããåå¿å³ã¡éåå¿äœçšãæããã
(3) åäŸ¡ã®æž¬å®æ³ ïŒâãã³ãžã«ããã³ãã€ã³
2.5mgã嫿ããPH8.0ã«èª¿æŽãã0.02Mããªã¹
âå¡©é
žãããã¢ãŒ0.8mlã«ã10mMå¡©åã³ãã«
ã0.1mlãé
µçŽ æ¶²0.1mlãå ãã35âã§30ååå¿
ãè¡ãããã30ååŸã«0.1Nã®å¡©é
žïŒmlãå ã
ãŠåå¿ã忢ãããæ¬åå¿ãèå±€ãã¬ãŒãã«ã¹
ãããããïœâãã¿ããŒã«ïŒé
¢é
žïŒæ°ŽïŒïŒïŒ
ïŒïŒïŒã®å±é溶åªã§å±éããã也ç¥åŸã10ïŒ
ïœ
âãžã¡ãã«ã¢ãããã³ãºã¢ã«ãããã®ã¢ã»ãã³
溶液ïŒ1.5Nå¡©é
žå«æïŒã§çºè²ããããã³ã·ã
ã¡ããªãŒã«ãããâã«ã«ãã¢ã€ã«ããšãã«ã¢
ã©ãã³ã®çæéãå®éãããæ¯å1.0ÎŒã¢ã«ã®ïŒ®
âã«ã«ãã¢ã€ã«ããšãã«ã¢ã©ãã³ãçæããã
ããã³ãã€ããŒãŒã®éãïŒåäœãšãã詊æã®ã
ãã³ãã€ããŒãŒå䟡ãç®åºããã
(4) å®å®PHã®ç¯å² ç·©è¡æ¶²ãšããŠãé
¢é
žç·©è¡æ¶²
ïŒ0.05Mé
¢é
žâé
¢é
žãããªãŠã PH4.0ã5.5ïŒããª
ã³é
žç·©è¡æ¶²ïŒ0.05Mãªã³é
žâã«ãªãŠã âãªã³é
ž
ïŒãããªãŠã ç·©è¡æ¶²PH5.5ã8.0ïŒãã¢ã³ã¢ãã¢
ç·©è¡æ¶²ïŒ0.05Mã¢ã³ã¢ãã¢æ°Žâå¡©åã¢ã³ã¢ããŠ
ã ç·©è¡æ¶²PH8.0ã10.0ïŒãããŠé
žç·©è¡æ¶²ïŒ0.05M
ããŠé
žâããŠé
žãããªãŠã PH9.5ã11.5ïŒãçš
ããŠãé
µçŽ æ¶²ãåPHã§ã35âã30åã€ã³ããŠã
ãŒãåŸãæ®ååäŸ¡ãæž¬å®ããããšã«ãã€ãŠæ±ã
ãå®å®PHç¯å²ã¯ã5.0ã10.0ã§ããã
(5) äœçšé©æž©ã®ç¯å² PH8.0ã§10ã30åéäœçšã
ããå Žåã30ã40âã®ç¯å²ãæé©ã§ããã
(6) PHãæž©åºŠçã«ããå€±æŽ»ã®æ¡ä»¶ PH4.0以äžå
ã³PH11以äžã§35âã30åã€ã³ããŠããŒããã
ãšãå®å
šã«å€±æŽ»ãããPH8.0ã«ãããŠ60âã§20
åéç±åŠçããããšã«ããå®å
šã«å€±æŽ»ããã
(7) é»å®³ã掻æ§ååã³å®å®å
â〠é»å®³
é»å®³å€ç¡æ·»å æã®é
µçŽ æŽ»æ§å€ã100ãšãããã
ãããå¡©åããã±ã«ãå¡©åé
ããšãŒãé
¢é
žã
PCMBããšãã¬ã³ãžã¢ãã³ããã©é
¢é
žãçªåã
ããªãŠã ãããããã·ã«ã¢ãã³å¡©é
žãæ·»å ããPH
8.0ãæž©åºŠ30âã30åéåå¿ããå Žåã®æ®å掻æ§
ã衚ã«ç€ºãããªããæ¬æŽ»æ§æž¬å®ã«ãããŠã³ãã«ã
ã€ãªã³ã¯æ·»å ããŠããªãã
[Industrial Application Field] The present invention relates to a novel hydantoinase.
More specifically, the present invention relates to a novel hydantoinase having the activity of cleaving and hydrolyzing a 5-substituted hydantoin to produce an N-carbamoyl-L-amino acid. [Prior art] Hydantoinase that acts on 5-substituted hydantoins is present in livers and kidneys of various animals, leguminous plants, and microorganisms, and cleaves and hydrolyzes dihydrouracil or dihydrothymine to produce N-carbamoyl, respectively. - Converts to β-alanine or N-carbamoyl-β-amino-isobutyric acid, and also acts on 5-substituted hydantoins, stereospecifically cleaves and hydrolyzes them, resulting in optically active N-carbamoyl-D-amino acids. Dihydropyrimidinase (EC3.5.2.2) which also has the action of converting to On the other hand, L-
Carboxymethylhydantoinase (EC3.5.2.4) that generates N-carbamoyl-L-aspartic acid from 5-carboxymethylhydantoin is known (Enzyme Handbook, Asakura Shoten, 1982, p. 597). As a method for producing L-amino acids from 5-substituted hydantoin, Japanese Patent Publication No. 42-13850 describes a method for producing L-amino acids using bacterial cells, culture fluids, and disrupted fluids of various microorganisms. â
No. 8633 describes a method for producing L-lysine, and Japanese Patent Publication No. 54-2274 and Japanese Patent Publication No. 54-8749 disclose a method for producing L-lysine from 5-substituted hydantoin by the action of Flavobacterium aminogenes. A method for producing alanine and L-tryptophan is disclosed. The present inventors have also proposed a method for producing L-amino acids by reacting Arylobacter strain DK-200 with a 5-substituted hydantoin (Japanese Patent Application No. 70906/1982). These methods are extremely effective in producing L-amino acids useful as medicines, raw materials for the chemical industry, and food additives, and are expected to have practical effects. [Problems to be Solved by the Invention] However, in these L-amino acid production methods, the enzyme that cleaves and hydrolyzes the 5-substituted hydantoin has not been clarified. If such an enzyme is available, useful L-amino acids can be produced economically and have great industrial value. Therefore, the present inventors developed a reaction to produce the corresponding L-amino acid from a 5-substituted hydantoin. As a result of research on microbial enzymes involved in This discovery led to the completion of the present invention. [Means for Solving the Problems] That is, the present invention has the following physical and chemical properties, and cleaves and hydrolyzes 5-substituted hydantoin to produce N-
It is a novel hydantoinase with the activity of producing carbamoyl-L-amino acids. Substrate specificity: Does not act on 5-carboxymethylhydantoin. Optimum pH: Hydrolysis reaction from 5-substituted hydantoin PH8.0-9.0 Reverse reaction from N-carbamoyl-amino acid
PH5.0 to 7.0 Stable PH range; PH5.0 to 10.0 Suitable temperature range for action; 30 to 40â Temperature stability range; Up to 35â, influence of stability inhibitors and metal ions; p-chloromercury benzoate ( PCMB), which is inhibited by ethylenediaminotetraacetic acid. The activity is promoted by cobalt ions, manganese ions, and zinc ions, and cobalt ions improve thermal stability. The present invention will be explained in more detail below. First, the physicochemical properties of this enzyme will be described below. (1) Action and substrate specificity This enzyme is a 5-substituted hydantoin in L form and D form.
The amino acids undergo cleavage hydrolysis and are converted into the corresponding N-carbamoyl-L-amino acids and N-carbamoyl-D-amino acids, respectively. Among 5-substituted hydantoins, it acts particularly well on 5-benzylhydantoin, 5-indolylmethylhydantoin, etc., which have an aromatic ring as a substituent. However, 5-carboxymethylhydantoin (DL-aspartate hydantoin) and DL
- Does not act on glutamate hydantoin and hydantoin. Therefore, it is a novel hydantoinase different from known carboxymethyl hydantoinases. Also, dihydrouracil and dihydrothymine,
It has little effect and is different from dihydropyrimidinase. (2) Optimal PH The optimal PH is determined by using ammonia buffer (0.05M aqueous ammonia-ammonium chloride buffer, PH8.0-10.0) as a buffer solution, using 5-benzylhydantoin as a substrate, and at a temperature of 35°C for 30 minutes. When the N-carbamoyl-DL-phenylalanine produced by the reaction is measured, the pH is 8.0-9.0. In addition, acetic acid buffer (0.05M
N
-carbamoyl-L-phenylalanine or N
The optimum pH is 5.0 to 7.0 when 5-benzylhydantoin production is measured using -carbamoyl-D-phenylalanine as a substrate. This enzyme is
It has a reaction to produce 5-substituted hydantoin from N-carbamoyl-L-amino acid and N-carbamoyl-D-amino acid, that is, it has a reverse reaction action. (3) Measurement method of potency 5-benzylhydantoin
To 0.8 ml of 0.02M Tris-HCl buffer containing 2.5 mg and adjusted to pH 8.0, 0.1 ml of 10 mM cobalt chloride and 0.1 ml of enzyme solution are added, and the reaction is carried out at 35°C for 30 minutes. After 30 minutes, 1 ml of 0.1N hydrochloric acid is added to stop the reaction. This reaction was spotted on a thin layer plate, and n-butanol:acetic acid:water=4:
Develop with a 1:1 developing solvent. After drying, 10% p
- Color is developed with an acetone solution of dimethylaminobenzaldehyde (containing 1.5N hydrochloric acid), and the amount of N-carbamoylphenylalanine produced is determined by densitometry. 1.0 ÎŒmol N per minute
- The amount of hydantoinase that produces carbamoylphenylalanine is taken as one unit, and the hydantoinase titer of the sample is calculated. (4) Stable PH range As buffer solutions, acetate buffer (0.05M acetic acid-sodium acetate PH4.0-5.5), phosphate buffer (0.05M phosphate-potassium-sodium phosphate buffer PH5.5-5.5) 8.0), ammonia buffer (0.05M aqueous ammonia-ammonium chloride buffer PH8.0-10.0), borate buffer (0.05M
The stable PH range was determined by measuring the residual titer after incubating the enzyme solution at 35â for 30 minutes at each pH using boric acid-sodium borate (PH9.5-11.5). It is 10.0. (5) Range of suitable temperature for action When allowed to work for 10 to 30 minutes at pH 8.0, the optimum temperature range is 30 to 40°C. (6) Conditions for inactivation due to PH, temperature, etc. Incubation at 35°C for 30 minutes at PH4.0 or below and PH11 or above completely inactivates. 20 at 60â at PH8.0
It is completely inactivated by heat treatment for a minute. (7) Inhibition, activation and stabilization âa Inhibition The enzyme activity value without the addition of inhibitor is 100, and the enzyme activity value is 100, respectively.
Add PCMB, ethylenediaminetetraacetic acid, sodium nitride, hydroxylamine hydrochloric acid, and PH
8.0, the residual activity after reaction at 30°C for 30 minutes is shown in the table. Note that cobalt ions were not added in this activity measurement.
ã衚ã
衚ãããæãããªåŠããPCMBã®ä»ã«ããšã
ã¬ã³ãžã¢ãã³ããã©é
¢é
žã«ãããæ¬é
µçŽ ã¯é¡èã«
é»å®³ãããéå±é
µçŽ ãšèããããã
âã æŽ»æ§å
æ¬é
µçŽ ã¯ã0.1ã10mMã®ã³ãã«ãã€ãªã³ãã
ã³ã¬ã³ã€ãªã³ãäºéã€ãªã³ããã°ãã·ãŠã ã€ãª
ã³ãéã€ãªã³ã®ãããªéå±ã€ãªã³ã®ååšäžã§åå¿
ããããšãç¡æ·»å ã®å Žåã«æ¯ã¹ã掻æ§ãä¿é²ãã
ãã
âã å®å®å
æ¬é
µçŽ ã¯ã0.1ã10mMã®ã³ãã«ãã€ãªã³ãå
±
åãããšç±å®å®æ§ãåäžãã40âã§ïŒæéãPHïŒ
ã§ã€ã³ããŠããŒããããšãç¡æ·»å ã®é
µçŽ ã®æ®å掻
æ§ã¯30ã40ïŒ
ãšãªããã1mMã³ãã«ãã€ãªã³å
±
åäžã§ã¯æŽ»æ§äœäžã¯èŠãããªãã
(8) ç²Ÿè£œæ¹æ³
å¹é€ç©ãé å¿åé¢ããŠæ¹¿æœ€èäœãéèãããã®
èäœã0.02Mããªã¹âå¡©é
žç·©è¡æ¶²ïŒPH8.0ãå¡©å
ãã³ã¬ã³1mM嫿ïŒã«æžæ¿ããè¶
鳿³¢åŠçã«ã
ããèäœãç Žç ããé å¿åé¢ã«ãŠåºåœ¢åãé€ãã
ç²é
µçŽ æ¶²ãåŸãã
次ãã§ããã®ç²é
µçŽ æ¶²ã«ãïŒïŒ
ããã¿ãã³ç¡«é
ž
氎溶液ïŒPH7.0ïŒãå ããçããæ²æŸ±ãé å¿åé¢
ã§é€ããæ¬¡ãã§ãã®äžæž
æ¶²ã«ç¡«é
žã¢ã³ã¢ããŠã ã
0.30飜åã«ãªããŸã§å ããçããæ²æŸ±ãé å¿åé¢
ã§é€ããåŸãããäžæž
æ¶²ã«æŽã«ç¡«é
žã¢ã³ã¢ããŠã
ã0.60飜åã«ãªããŸã§å ããçããæ²æŸ±ãåé¢ã
ãŠã0.02Mããªã¹âå¡©é
žç·©è¡æ¶²ïŒPH8.0ãå¡©åã
ã³ã¬ã³1mM嫿ïŒã«æº¶è§£ãããã®æº¶æ¶²ãåç·©è¡
æ¶²ã§24æééæããã
以äžã®ããã«ããŠåŸãç¡«å®åç»ããäžèšç·©è¡æ¶²
ã§å¹³è¡¡åããèçœç²Ÿè£œçšé°ã€ãªã³äº€ææš¹èã«ã©ã
ïŒMONO ãã¢ãã·ã¢è£œïŒã«ããæ¶²äœã¯ããã
ã°ã©ãã€ãŒã«ãããé
µçŽ ãã«ã©ã ã«åžçãããã
次ãã§ãå¡©åãããªãŠã æ¿åºŠãïŒã1Mã«çŽç·ç
ã«å¢å ãããäžèšç·©è¡æ¶²ãæµããŠãæµåºæ¶²ããã©
ã¯ã·ãšã³ã³ã¬ã¯ã¿ãŒã§åç»ããæŽ»æ§åºåãéã
ãã
次ãã§ãã®æŽ»æ§åºåãã0.05Mããªã¹å¡©é
žç·©è¡
æ¶²ïŒ0.2Må¡©åãããªãŠã ã1mMå¡©åãã³ã¬ã³å«
æïŒã§å¹³è¡¡åããã²ã«ãéçšã«ã©ã ïŒG3000SW
ÃïŒæ±æŽæ¹éå·¥æ¥ç€Ÿè£œïŒã«ãããåçµæã®ç·©è¡æ¶²
ã§æº¶åºããæŽ»æ§åºåãéããããã®æŽ»æ§åºåãå
床ãã²ã«ãéçšã«ã©ã ã«ãããŠãã¯ãããã°ã©ã
ã€ãŒãè¡ããæŽ»æ§åºåã粟補æšåãšããã
(9) ååé
æ¬é
µçŽ ã®ååéã¯é«éæ¶²äœã¯ãããã°ã©ãã€ãŒ
ïŒG3000SWÃïŒæ±æŽæ¹éå·¥æ¥ç€Ÿè£œïŒã«ããã²ã«ã
éæ³ã§æž¬å®ããçµæãçŽ20äžã§ããããšãã¬ã³ãž
ã¢ãã³ããã©é
¢é
žåŠçœ®ããŠåŸæž¬å®ãããšãçŽ10äž
ã§ããããããã®ååéã®ç°ãªãé
µçŽ ã¯ãååé
ã®ç°ãªãããšä»¥å€ã¯ããã®çååŠçæ§è³ªã«ãããŠ
åæ§ã§ããã
(10) çé»ç¹ MONOPïŒãã¢ãã·ã¢è£œïŒãçšã
ããã¯ãããããªãŒã«ã·ã³ã°æ³ã«ããæž¬å®ãã
çµæïŒã4.5ã§ãã€ãã
æ¬é
µçŽ ã¯ã以äžã®æ§è³ªããæ°èŠããã³ãã€ããŒ
ãŒãšèªããããæ¬é
µçŽ ã®æ§è³ªã掻çšããã°ã極ã
ãŠæçšãªïŒ®âã«ã«ãã¢ã€ã«ââã¢ããé
žè£œé ã
å¯èœãšãªãã
æ¬¡ã«æ¬é
µçŽ ã補é ããããã®å
·äœçææ®µã以äž
ã«è¿°ã¹ããæ¬é
µçŽ ã補é ããæ¹æ³ãšããŠã¯åŠäœãª
ãæ¹æ³ã§ãè¯ããäŸãã°ä»¥äžã®æ¹æ³ãæããã
ãã
å
ããæ¬é
µçŽ ã補é ããã«ããã䜿çšãããè
ãšããŠã¯ãã¢ãªã¹ããã¯ã¿ãŒå±ã«å±ããäžèšãã
ã³ãã€ããŒãŒçç£èœãæããèã§ããã°åŠäœãªã
èã§ãããããŸããããã®èã®å€çš®ãããã¯å€ç°
æ ªã§ãè¯ãããããŠãã¢ãªãããã¯ã¿ãŒå±ã«å±
ããæ°èŠããã³ãã€ããŒãŒçç£èœãæããèã®å
·
äœäŸãšããŠãäŸãã°ã¢ãªã¹ããã¯ã¿ãŒå±
ïŒArthroâbacter SPïŒDKâ200ãæããããã
äžèšã¢ãªã¹ããã¯ã¿ãŒDKâ200ã¯æ¬çºæè
ã
ããåå£äžããæ°ãã«æ€çŽ¢ããŠåŸãèæ ªã§ããã®
èåŠçæ§è³ªã¯ã以äžã«ç€ºãéãã§ããã
ã¢ãªã¹ããã¯ã¿ãŒDKâ200ã®èåŠçæ§è³ª
(a) 圢æ
çé¡åŸ®é¡ç芳å¯
(1)现èã®åœ¢åã³å€§ããïŒ0.3ã0.5ÎŒÃ0.8ã
5.0ÎŒmã®æ¡¿èã§ããã
(2)现èã®å€åœ¢æ§ã®æç¡ïŒå€åœ¢æ§ãèªãããã
(3)éåã®æç¡ïŒéåæ§ãªãïŒéæ¯ã¯èªããããª
ããïŒ
(4)èåã®æç¡ïŒãªã
(5)ã°ã©ã æè²ïŒé°æ§ãåŒ±éœæ§ã ãã°ã©ã éœæ§ç²
åãæãã
(6)æé
žæ§ïŒé°æ§
(b) åå¹å°ã§ã®çè²ç¶æ
(1)èæ±å¯å€©å¹³æ¿å¹é€ïŒã³ãããŒã®åœ¢ç¶ã¯å圢
ã§ãéèµ·ã¯åžç¶ã§ãããåšèŸºã¯å
šçžç¶ã§ã
ããã³ãããŒã®è²ã¯æ·¡çœè²ã§ããã
(2)èæ±å¯å€©æé¢å¹é€ïŒé©åºŠã®çè²ç¶æ
ã§ç³žç¶ã®
çè²ã瀺ããå
æ²¢ããã
(3)èæ±æ¶²äœå¹é€ïŒæ··æ¿ã®çšåºŠã¯åäžã§ãæ¶²é¢ã§
ã®çè²ã¯ç¹ã«ãªããæ²æŸ±ããã
(4)èæ±ãŒã©ãã³ç©¿åºå¹é€ïŒæ¶²åããã
(5)ãªããã¹ãã«ã¯å¹é€ïŒäžæ§ã§æ¶²äœããªãã
(c) çççæ§è³ª
(1)ç¡é
žå¡©ã®éå
ïŒéå
ããªãã
(2)è±çªåå¿ïŒéœæ§
(3)MRãã¹ãïŒé°æ§
(4)VPãã¹ãïŒé°æ§
(5)ã€ã³ããŒã«ã®çæïŒçæããªãã
(6)ç¡«åæ°ŽçŽ ã®çæïŒçæããªãã
(7)ãã³ãã³å æ°Žåè§£ïŒå æ°Žåè§£ããªãã
(8)ã¯ãšã³é
žã®å©çšïŒäž¡æ¹ãšãå©çšããªãã
ïŒKosevã®å¹å°åã³Christensenã®å¹å°äœ¿çš
(9)ç¡æ©çªçŽ æºã®å©çšïŒå©çšãããïŒç¡é
žå¡©åã³
ã¢ã³ã¢ããŠã å¡©ïŒ
(10)è²çŽ ã®çæïŒçæããªã
(11)ãŠã¬ã¢ãŒãŒïŒé°æ§
(12)ãªãã·ããŒãŒïŒé°æ§
(13)ã«ã¿ã©ãŒãŒïŒéœæ§
(14)é
žçŽ ã«å¯Ÿããæ
床ïŒå¥œæ°æ§
(15)çè²ã®ç¯å²ïŒæž©åºŠïŒ17.8ã33.2â
PHïŒïŒã10
(16)âãã¹ãïŒé
žå
(17)ç³é¡ããã®é
žåã³ã¬ã¹ã®çæã®æç¡ïŒ[Table] As is clear from the table, this enzyme is significantly inhibited by ethylenediaminetetraacetic acid in addition to PCMB, and is considered to be a metalloenzyme. âB Activation When this enzyme is reacted in the presence of 0.1 to 10mM of metal ions such as cobalt ions, manganese ions, zinc ions, magnesium ions, and iron ions, the activity is promoted compared to when no additives are used. Ru. âC Stabilization The thermostability of this enzyme improves when 0.1-10mM cobalt ions coexist,
When incubated with 1mM cobalt ion, the residual activity of the enzyme without additives is 30-40%, but no decrease in activity is observed in the presence of 1mM cobalt ion. (8) Purification method Centrifuging the culture to collect wet bacterial cells, suspending the bacterial cells in 0.02M Tris-HCl buffer (PH8.0, containing 1mM manganese chloride), and applying sonication to Crush the bacterial cells, remove solids by centrifugation,
Obtain crude enzyme solution. Next, 3% protamine sulfate aqueous solution (PH7.0) was added to the crude enzyme solution, the resulting precipitate was removed by centrifugation, and ammonium sulfate was added to the supernatant.
Add 0.30 to saturation, and remove the precipitate by centrifugation. Ammonium sulfate was further added to the obtained supernatant until the saturation reached 0.60, and the resulting precipitate was separated and dissolved in 0.02M Tris-HCl buffer (PH8.0, containing 1mM manganese chloride), and this solution was added to the same solution. Dialyze for 24 hours against buffer. The ammonium sulfate fraction obtained as described above is subjected to liquid chromatography using an anion exchange resin column for protein purification (MONO Q manufactured by Pharmacia) equilibrated with the above buffer solution, and the enzyme is adsorbed onto the column.
Then, the above-mentioned buffer solution with increasing sodium chloride concentration linearly from 0 to 1M is passed through the tube, and the effluent is fractionated with a fraction collector to collect the active fraction. The active fraction was then transferred to a gel filtration column (G3000SW) equilibrated with 0.05M Tris-HCl buffer (containing 0.2M sodium chloride, 1mM manganese chloride).
Ã2 manufactured by Toyo Soda Kogyo Co., Ltd.), elute with a buffer solution of the same composition, and collect the active fraction. This active fraction is applied to a gel filtration column again, chromatography is performed, and the active fraction is used as a purified sample. (9) Molecular weight The molecular weight of this enzyme was measured by gel filtration using high-performance liquid chromatography (G3000SW x 2 manufactured by Toyo Soda Kogyo Co., Ltd.) and was approximately 200,000, and when measured after treatment with ethylenediaminetetraacetic acid, it was approximately 200,000. It is 100,000. These enzymes with different molecular weights are similar in their physicochemical properties except for their different molecular weights. (10) Isoelectric point The result was 4 to 4.5 as measured by the chromatofocusing method using MONOP (manufactured by Famacia). This enzyme is recognized as a novel hydantoinase based on the above properties, and by utilizing the properties of this enzyme, it becomes possible to produce extremely useful N-carbamoyl-L-amino acids. Next, specific means for producing the present enzyme will be described below. Any method may be used to produce the present enzyme, including the following methods. First, the bacteria used to produce the present enzyme may be any bacteria that belongs to the genus Arylobacter and has the ability to produce the above-mentioned hydantoinase, or may be a variant or mutant strain of these bacteria. A specific example of a bacterium belonging to the genus Arimalobacter and having the ability to produce a novel hydantoinase includes, for example, Arthro-bacter SP DK-200. The above-mentioned Arylobacter DK-200 is a strain newly obtained by the present inventors from soil, and its mycological properties are as shown below. Mycological properties of Arylobacter DK-200 (a) Morphological microscopic observation (1) Cell shape and size: 0.3-0.5ÎŒ x 0.8-
It is a rod of 5.0 ÎŒm. (2) Presence or absence of cell pleomorphism: Pleomorphism is observed (3) Presence or absence of movement: No motility (flagellates are not observed) (4) Presence or absence of spores: None (5) Gram staining: Negative ~ Weakly positive but with Gram-positive particles (6) Acid-fast: Negative (b) Growth status in each medium (1) Broth agar plate culture: Colonies are circular in shape, the ridges are convex, and the periphery is entirely It is edge-shaped and the color of the colony is pale white. (2) Broth agar slant culture: shows filamentous growth under moderate growth conditions. Glossy (3) Meat juice liquid culture: The degree of turbidity is uniform, and there is no particular growth on the liquid surface. There is a precipitate (4) Meat juice gelatin puncture culture: Liquefies. (5) Litmus milk culture: Neutral and non-liquid. (c) Physiological properties (1) Reduction of nitrate: No reduction. (2) Denitrification reaction: Positive (3) MR test: Negative (4) VP test: Negative (5) Indole production: Not produced. (6) Generation of hydrogen sulfide: Not generated. (7) Starch hydrolysis: Not hydrolyzed. (8) Use of citric acid: Do not use either. (Using Kosev's medium and Christensen's medium (9) Utilization of inorganic nitrogen sources: Utilize (nitrates and ammonium salts) (10) Pigment production: No production (11) Urease: Negative (12) Oxidase: Negative (13 ) Catalase: Positive (14) Attitude towards oxygen: Aerobic (15) Growth range: Temperature: 17.8-33.2â PH: 5-10 (16) O-F test: Oxidation (17) Acids and gases from sugars Whether or not to generate:
以äžå®æœäŸãæããŠãæ¬çºæãå
·äœçã«èª¬æã
ãããæ¬çºæã¯ãããã«éå®ããããã®ã§ã¯ãª
ãã
宿œäŸ ïŒ
ããã³ãã€ããŒãŒã®è£œé äŸ
ããªãããã³1.0ïœãé
µæ¯ãšãã¹1.0ïœãã°ã«ã³
ãŒã¹1.0ïœãå¡©åãããªãŠã 1.0ïœãâã«ã«ãã¢
ã€ã«ããªãããã¢ã³0.2ïœãæ°Žéæ°Žã«æº¶è§£ããã
ã®PHã7.5ã«èª¿æŽããå
šéã200mlãšãããã®500
mlã®åå£ãã©ã¹ã³ã«100mlãã€ïŒæ¬å泚ãããã
ã®å¹å°ã枩床120âã§15åéæ®ºèåŸãã¢ãªã¹ãã
ã¯ã¿ãŒDKâ200ïŒåŸ®å·¥ç èäžç¬¬7472å·ïŒãæ¥çš®
ããæž©åºŠ30âã§20æéæ¯çªå¹é€ïŒ100s.p.mã®åŸ
埩ïŒããã
å¹é€çµäºåŸå¹é€æ¶²200mlãé å¿åé¢ããŠåŸãã
ãèäœãççé£å¡©æ°Žã§ïŒåæŽæµåŸã0.02Mããªã¹
âå¡©é
žç·©è¡æ¶²ïŒPH8.0ãå¡©åãã³ã¬ã³1mM嫿ïŒ
ã«æžæ¿ããæ¶²éã20mlã«ããããã®èäœæžæ¿æ¶²ã
10mlãã€ã«åãã20K Hzã®è¶
鳿³¢ç Žç æ©ã§ãã
ãããïŒåéïŒååŠçããŠãé å¿åé¢ããåºåœ¢å
ãé€å»ããç²é
µçŽ æ¶²ãåŸãããã®ç²é
µçŽ æ¶²ãéã
ãŠãäžèšããªã¹âå¡©é
žç·©è¡æ¶²ã§30mlãšããåŸãïŒ
ïŒ
ããã¿ãã³ç¡«é
žæ°Žæº¶æ¶²ïŒmlãæªæããªããå
ãã30åéæªæãç¶ãããé å¿åé¢ã«ãã€ãŠæ²æ®¿
ãé€å»ããäžæž
æ¶²ãåŸãããã®äžæž
æ¶²ã«ãç¡«é
žã¢
ã³ã¢ããŠã ã0.30飜åã«ãªããŸã§å ããçããæ²
殿ãé å¿åé¢ã§é€ããåŸãããäžæž
æ¶²ã«æŽã«ç¡«é
ž
ã¢ã³ã¢ããŠã ã0.60飜åã«ãªããŸã§å ããé å¿å
é¢ã«ããæ²æ®¿ãåŸãããã®æ²æ®¿ãã0.02Mããªã¹
âå¡©é
žç·©è¡æ¶²ïŒPH8.0ãå¡©åãã³ã¬ã³1mM嫿ïŒ
ã«æº¶è§£ãããã®æº¶æ¶²ãåç·©è¡æ¶²ã§24æééæãã
10mlã®é
µçŽ æ¶²ãåŸãã
以äžã®ããã«ããŠç¡«å®åç»æ¶²ïŒmlãã0.02Mã
ãªã¹âå¡©é
žç·©è¡æ¶²ïŒPH8.0ãå¡©åãã³ã¬ã³1mMå«
æïŒã§å¹³è¡¡åããèçœç²Ÿè£œçšé°ã€ãªã³äº€ææš¹èã«
ã©ã ïŒMono ãã¢ãã·ã¢ç€Ÿè£œïŒã«åžçãããã
次ãã§ãé«éæ¶²äœã¯ãããã°ã©ãã€ãŒã«ãããã
ã®ç·©è¡æ¶²ãçšããŠå
åã«æŽæµããé£å¡©æ¿åºŠãïŒã
1.0MãŸã§é£ç¶çã«äžæãããæ¹æ³ã«ããæº¶åºã
è¡ãªããã©ã¯ã·ãšã³ã³ã¬ã¯ã¿ãŒã§åç»ããæŽ»æ§åº
åãåŸããæ¬é«éæ¶²äœã¯ãããã°ã©ãã€ãŒãïŒå
è¡ãªãããšã«ããã10mlã®ç¡«å®åç»æ¶²ããã®é°ã€
ãªã³äº€ææš¹è粟補é
µçŽ æ¶²ãåŸãããããã®é
µçŽ æ¶²
ã«0.80飜åç¡«é
žã¢ã³ã¢ããŠã ãå ããŠå¡©æããæ¿
çž®é
µçŽ æ¶²ãïŒmlåŸãã
次ãã§ã0.2Må¡©åãããªãŠã ã1mMå¡©åãã³
ã¬ã³ã嫿ãã0.05Mããªã¹å¡©é
žç·©è¡æ¶²ã§å¹³è¡¡å
ããã²ã«ãéçšã«ã©ã ïŒG3000SWÃïŒãæ±æŽæ¹
é補ïŒã«ãããé«éæ¶²äœã¯ãããã°ã©ãã€ãŒã«ã
ããåç·©è¡æ¶²ã§æº¶åºããæŽ»æ§åºåãéããããã®
掻æ§åºåãå床ãåãã²ã«ãéçšã«ã©ã ã«ããã
é«éæ¶²äœã¯ãããã°ã©ãã€ãŒã«ããéããæŽ»æ§åº
åã粟補é
µçŽ æ¶²ãšãããæ¬é
µçŽ æ¶²ã®èçœæ¿åºŠãã
ãããã€ã³ã»ã¢ãã»ã€ïŒãã€ãªã©ãã瀟補ïŒã«ã
ãæž¬å®ããæŽ»æ§ã枬å®ãããšãããæ¯æŽ»æ§34.2å
äœïŒmgã§ãã€ãã
æ¬çºæã®ããã³ãã€ããŒãŒã®å©çšäŸ
æ¬é
µçŽ æ¶²0.5åäœãçšããïŒâãã³ãžã«ããã³
ãã€ã³ïŒmgã0.02Mããªã¹âå¡©é
žãããã¢ãŒïŒPH
ïŒïŒïŒ1mMå¡©åã³ãã«ããå«ãïŒmlã®æº¶æ¶²äžã35
âã15æéåå¿ããããç
®æ²žã«ããåå¿ã忢ã
ãŠåŸçæããâã«ã«ãã¢ã€ã«âããšãã«ã¢ã©ã
ã³ãèå±€ã¯ãããã°ã©ãã€ãŒã«ãããïœâãã¿ã
ãŒã«ïŒé
¢é
žïŒæ°ŽïŒïŒïŒïŒïŒïŒã§å±éããïœâãžã¡
ãã«ã¢ãããã³ãºã¢ã«ããã詊è¬ã§çºè²ãããã
ã³ã·ãã¡ããªãŒã«ããå®éãããšããã2.1mgïŒ
mlã®ïŒ®âã«ã«ãã¢ã€ã«ããšãã«ã¢ã©ãã³ãçæã
ãŠããããã®åå¿æ¶²ã«ïŒ®âã«ã«ãã¢ã€ã«ââã¢
ããé
žã«ç¹ç°çã«åå¿ããŠïŒ¬âã¢ããé
žãçæã
ãã·ãŠãŒãã¢ãã¹DKâ910埮工ç èå¯ç¬¬7473å·
ïŒFERM â7473ïŒã®é
µçŽ ã0.05Mããªã¹ã»å¡©é
ž
ç·©è¡æ¶²ïŒPH8.0ïŒäžã35âã15æéåå¿ãããã
çæããâããšãã«ã¢ã©ãã³ãã©ã¯ãããã«
ã¹ãã¢ã©ããã¶ã¹ATCC8014ãçšãããã€ãªã¢ã
ã»ã€æ³ã«ããæž¬å®ãããšããã0.83mgã®ïŒ¬âããš
ãã«ã¢ã©ãã³ãçæããŠããïŒã¢ã«åç49.8ïŒ
察
âã«ã«ãã¢ã€ã«ããšãã«ã¢ã©ãã³ïŒã
宿œäŸ ïŒ
æ¬çºæããã³ãã€ããŒãŒã®å©çšäŸ
宿œäŸïŒãšåæ§ã«ããŠåŸãé
µçŽ æ¶²ãçšããïŒâ
ãã³ãžã«ããã³ãã€ã³ã®ãããã«ãïŒâã€ã³ããª
ã«ã¡ãã«ããã³ãã€ã³ãçšããŠã宿œäŸïŒãšåæ§
ã«ããŠåå¿ããããçæããâã«ã«ãã¢ã€ã«â
ããªãããã¢ã³ã宿œäŸïŒãšåæ§ã«ããŠèå±€ã¯ã
ããã°ã©ãã€ãŒã«ããå®éãããšãã2.1mgïŒml
ã®ïŒ®âã«ã«ãã¢ã€ã«ããªãããã¢ã³ãçæããŠã
ãããã®åå¿æ¶²ã«å®æœäŸïŒãšåæ§ã«ããŠãã·ãŠãŒ
ãã¢ãã¹DKâ910埮工ç èå¯ç¬¬7473å·ïŒFERM
â7473ïŒã®é
µçŽ ãåå¿ããããçæããâã
ãªãããã¢ã³ããã€ãªã¢ãã»ã€æ³ã«ãããæž¬å®ã
ããšããã0.86mgã®ïŒ¬âããªãããã¢ã³ãçæã
ãŠããïŒã¢ã«åç49.6ïŒ
察âã«ã«ãã¢ã€ã«ããª
ãããã¢ã³ïŒã
ãçºæã®å¹æã
ææ©åæååŠçã«è£œé ãããïŒâ眮æããã³ã
ã€ã³ãããæ¬é
µçŽ ã«ãã€ãŠåžžæž©åžžå§ã®æž©åãªæ¡ä»¶
äžã§ãå¹çãããâã«ã«ãã¢ã€ã«ââã¢ãã
é
žã補é ããããšãå¯èœã§ãããããã«ãæ¬é
µçŽ
ã¯ïŒ®âã«ã«ãã¢ã€ã«ââã¢ããé
žå æ°Žåè§£é
µçŽ
ãšã®äœµçšãããã¯é次åå¿ã«ããå»è¬ã»é£åæ·»å
ç©çãšããŠæçšãªïŒ¬âã¢ããé
žã®è£œé ã«æå¹ã§ã
ãã
The present invention will be specifically described below with reference to Examples, but the present invention is not limited thereto. Example 1 Production example of hydantoinase 1.0 g of polypeptone, 1.0 g of yeast extract, 1.0 g of glucose, 1.0 g of sodium chloride, and 0.2 g of N-carbamoyl tryptophan were dissolved in tap water, the pH was adjusted to 7.5, and the total amount was dissolved. 200ml 500
The mixture was dispensed into two 100 ml Sakaguchi flasks. After sterilizing this medium at a temperature of 120°C for 15 minutes, it was inoculated with Arylobacter DK-200 (Feiko Kenboku Yo No. 7472) and cultured with shaking (100 s.pm back and forth) at a temperature of 30°C for 20 hours. After culturing, 200 ml of the culture solution was centrifuged, the resulting bacterial cells were washed once with physiological saline, and then added to 0.02M Tris-HCl buffer (PH8.0, containing 1mM manganese chloride).
The suspension was made into a liquid volume of 20 ml. This bacterial suspension
The mixture was divided into 10 ml portions, each treated once for 3 minutes using a 20K Hz ultrasonic crusher, and centrifuged to remove solids to obtain a crude enzyme solution. The crude enzyme solution was collected and made up to 30 ml with the above Tris-HCl buffer, and then
% protamine sulfate aqueous solution was added with stirring, and stirring was continued for 30 minutes. The precipitate was removed by centrifugation to obtain a supernatant. Add ammonium sulfate to the supernatant until the saturation is 0.30, and remove the resulting precipitate by centrifugation. Ammonium sulfate is further added to the obtained supernatant until the saturation is 0.60, and a precipitate is obtained by centrifugation. This precipitate was dissolved in 0.02M Tris-HCl buffer (PH8.0, containing 1mM manganese chloride).
This solution was dialyzed against the same buffer for 24 hours,
10 ml of enzyme solution was obtained. As described above, 5 ml of the ammonium sulfate fraction was adsorbed onto an anion exchange resin column for protein purification (manufactured by Mono Q Famacia) equilibrated with 0.02 M Tris-HCl buffer (PH 8.0, containing 1 mM manganese chloride). let
Next, by high-performance liquid chromatography, the buffer solution was used to thoroughly wash the solution, and the salt concentration was adjusted to 0 to 0.
Elution was performed by continuously increasing the concentration to 1.0M, and the active fraction was obtained by fractionation using a fraction collector. By performing this high performance liquid chromatography twice, an anion exchange resin purified enzyme solution was obtained from 10 ml of the ammonium sulfate fraction. This enzyme solution was salted out by adding 0.80 saturated ammonium sulfate to obtain 2 ml of concentrated enzyme solution. Next, it was applied to a gel filtration column (G3000SW x 2, manufactured by Toyo Soda) equilibrated with 0.05M Tris-HCl buffer containing 0.2M sodium chloride and 1mM manganese chloride, and eluted with the same buffer using high performance liquid chromatography. and collected the active categories. This active fraction was applied to the same gel filtration column again.
The active fraction collected by high performance liquid chromatography was used as a purified enzyme solution. The protein concentration of this enzyme solution is
When the activity was measured using a protein assay (manufactured by Bio-Rad), the specific activity was 34.2 units/mg. Example of using the hydantoinase of the present invention Using 0.5 units of the present enzyme solution, 2 mg of 5-benzylhydantoin, 0.02M Tris-HCl buffer (PH
8), 35 in 1 ml of solution containing 1mM cobalt chloride
â for 15 hours. After stopping the reaction by boiling, the generated N-carbamoyl-phenylalanine was developed by thin layer chromatography with n-butanol:acetic acid:water=4:1:1, and colored with p-dimethylaminobenzaldehyde reagent. When quantified by densitometry, it was found that 2.1mg/
ml of N-carbamoylphenylalanine was produced. The enzyme of Pseudomonas DK-910 FERM P-7473, which reacts specifically with N-carbamoyl-L-amino acids to produce L-amino acids, was added to this reaction solution in 0.05 M Tris/HCl. The reaction was carried out in a buffer solution (PH8.0) at 35°C for 15 hours.
When the produced L-phenylalanine was measured by a bioassay method using Lactobacillus arabinosus ATCC8014, 0.83 mg of L-phenylalanine was produced (molar yield 49.8% vs. N-carbamoylphenylalanine). Example 2 Example of using the hydantoinase of the present invention Using an enzyme solution obtained in the same manner as in Example 1, 5-
A reaction was carried out in the same manner as in Example 1 except that 5-indolylmethylhydantoin was used instead of benzylhydantoin. The generated N-carbamoyl-
Tryptophan was quantified by thin layer chromatography in the same manner as in Example 1 and found to be 2.1 mg/ml.
of N-carbamoyltryptophan was produced. This reaction solution was treated with Pseudomonas DK-910 (FERM Bacteria No. 7473) in the same manner as in Example 1.
P-7473) enzyme was reacted. When the produced L-tryptophan was measured by a bioassay method, 0.86 mg of L-tryptophan was produced (molar yield 49.6% vs. N-carbamoyltryptophan). [Effect of the invention] It is possible to efficiently produce N-carbamoyl-L-amino acids from 5-substituted hydantoin produced by organic synthetic chemistry using the present enzyme under mild conditions at room temperature and normal pressure. It is. Furthermore, this enzyme is effective in producing L-amino acids useful as pharmaceuticals, food additives, etc. by combination or sequential reaction with N-carbamoyl-L-amino acid hydrolase.
Claims (1)
ã³ãã€ã³ãéè£å æ°Žåè§£ããŠïŒ®âã«ã«ãã¢ã€ã«â
âã¢ããé žãçæããæŽ»æ§ãæããæ°èŠããã³
ãã€ããŒãŒã åºè³ªç¹ç°æ§ïŒïŒâã«ã«ããã·ã¡ãã«ããã³ãã€
ã³ã«äœçšããªãã è³é©PHïŒïŒâ眮æããã³ãã€ã³ããã®å æ°Žåè§£
åå¿PH8.0ã9.0 âã«ã«ãã¢ã€ã«âã¢ããé žããã®éåå¿
PH5.0ã7.0 å®å®PHç¯å²ïŒPH5.0ã10.0 äœçšé©æž©ã®ç¯å²ïŒ30ã40â æž©åºŠå®å®æ§ã®ç¯å²ïŒ35âãŸã§ã¯å®å® é»å®³å€ãéå±ã€ãªã³ã®åœ±é¿ïŒïœâã¯ããããŒã
ãŠãªãã³ãŸãšã€ãããšãã¬ã³ãžã¢ãã³ãã
ã©é ¢é žã«ãã€ãŠé»å®³ããããã³ãã«ãã€ãª
ã³ããã³ã¬ã³ã€ãªã³ãäºéã€ãªã³ã«ãã€ãŠ
掻æ§ãä¿é²ããããã³ãã«ãã€ãªã³ã¯ç±å®
宿§ãåäžãããã[Scope of Claims] 1. N-carbamoyl-
A novel hydantoinase having the activity of producing L-amino acids. Substrate specificity: Does not act on 5-carboxymethylhydantoin. Optimum pH: Hydrolysis reaction from 5-substituted hydantoin PH8.0-9.0 Reverse reaction from N-carbamoyl-amino acid
PH5.0 to 7.0 Stable PH range; PH5.0 to 10.0 Suitable temperature range for action; 30 to 40â Temperature stability range; Up to 35â, influence of stability inhibitors and metal ions; p-chloromercuryuribenzoate, Cobalt ion improves thermal stability, activity promoted by cobalt, manganese, and zinc ions, inhibited by ethylenediaminetetraacetic acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9957884A JPS60241888A (en) | 1984-05-17 | 1984-05-17 | Novel hydantoinase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9957884A JPS60241888A (en) | 1984-05-17 | 1984-05-17 | Novel hydantoinase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60241888A JPS60241888A (en) | 1985-11-30 |
| JPH05993B2 true JPH05993B2 (en) | 1993-01-07 |
Family
ID=14250982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9957884A Granted JPS60241888A (en) | 1984-05-17 | 1984-05-17 | Novel hydantoinase |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60241888A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3535987A1 (en) * | 1985-10-09 | 1987-04-23 | Basf Ag | METHOD FOR PRODUCING MEOPHILIC MICROORGANISMS THAT CONTAIN D-HYDANTOINASE ACTIVE AT HIGHER TEMPERATURE |
| WO1994000577A1 (en) * | 1992-06-30 | 1994-01-06 | Smithkline Beecham P.L.C. | D-n-carbamoyl-amino acid amidohydrolase and hydantoinase |
-
1984
- 1984-05-17 JP JP9957884A patent/JPS60241888A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60241888A (en) | 1985-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS61268178A (en) | Fructosylamino acid oxidase and production thereof | |
| JPH08289786A (en) | Glucosamine-6-phosphate deaminase | |
| JPH05993B2 (en) | ||
| JPH0379999B2 (en) | ||
| JP2843596B2 (en) | Process for producing novel D-amidase and D-α-alanine and / or L-α-alanine amide | |
| US4918012A (en) | Method for producing carnitine, L-carnitinamide hydrolase and method for producing same | |
| JPH02234678A (en) | Amino acid amide hydrolase and use thereof | |
| JP2684238B2 (en) | Acylcarnitine esterase and method for producing the same | |
| JPH01228468A (en) | Hydroxamic acid hydrolase | |
| JPS6058068A (en) | Novel amine dehydrogenase and oxidation of amine using it | |
| JP2615443B2 (en) | Method for producing N-acetyl-D-glucosamine deacetylase | |
| JPH022597B2 (en) | ||
| JPS6248379A (en) | Production of cephalosporin c acylase | |
| JPH05236955A (en) | Production of heat-resistant alkaline phosphatase | |
| JPH05260964A (en) | Novel enzyme, method for producing the same, and method for producing D-lactic acid using the enzyme | |
| FR2517698A1 (en) | METHOD FOR DETERMINING ETHANOLAMINE | |
| JPS6139035B2 (en) | ||
| JPH0147150B2 (en) | ||
| JPH0614772A (en) | New ester hydrolase a and its production | |
| JPS61173789A (en) | Production of 4-chloro-3-hydroxybutyric acid | |
| JPS6318471B2 (en) | ||
| JPH0337B2 (en) | ||
| JPS62118882A (en) | L-arginine oxidase and its production | |
| JPS61219384A (en) | Production of n-acylneuraminic acid aldolase | |
| JPH07184647A (en) | α-L-fucosidase, its production method and Alcaligenes denitrificans sub sp. Denitrificans KSF-0901 strain |